Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaya Diagnostic CentreBOM:543350 -5.16%83 Pretax Margin % is 29.30% as of Mar. 2026, which is 3% above its 10-year median of 28.47. GuruFocus rates BOM:543350 with a GF Score™ of 83/100 and a GF Value™ of ₹1,191.11 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks better than 96.04% on this metric.
The historical rank and industry rank for Vijaya Diagnostic Centre's Pretax Margin % or its related term are showing as below:
BOM:543350'
s Pretax Margin % Range Over the Past 10 Years
Min: 22.33 Med: 28.47 Max: 31.89
Current: 28.58
BOM:543350's Pretax Margin % is ranked better than 96.04% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.565
vs BOM:543350: 28.58
Vijaya Diagnostic Centre (BOM:543350) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Vijaya Diagnostic Centre Pretax Margin % Related Terms
Vijaya Diagnostic Centre Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543350 vs TMO, DHR, IDXX: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaya Diagnostic Centre (BOM:543350) has a Pretax Margin % of 29.30% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vijaya Diagnostic Centre and its competitors. This is near median its historical median of 28.47. Over the past decade, Vijaya Diagnostic Centre's Pretax Margin % has ranged from 22.33 to 31.89. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #8 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 4%.
Is Vijaya Diagnostic Centre's Pretax Margin % too high?
Vijaya Diagnostic Centre's current Pretax Margin % of 29.30% is near median its 10-year median of 28.47. Over the past 10 years, this metric has ranged from a low of 22.33 to a high of 31.89. Based on the distribution chart, Vijaya Diagnostic Centre ranks #8 out of 202 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaya Diagnostic Centre has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's Pretax Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #8 out of 202 companies for Pretax Margin %. This places Vijaya Diagnostic Centre in the top 4% of its industry — outperforming the majority of peers. Historically, Vijaya Diagnostic Centre's own Pretax Margin % has ranged from 22.33 to 31.89 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vijaya Diagnostic Centre and its competitors. Vijaya Diagnostic Centre's current Pretax Margin % is 29.30%, which is near median its own 10-year median of 28.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,191.11, compared to a current price of ₹1,341.10 — trading 12.6% above its estimated fair value. The current Pretax Margin % is 29.30%, which is near median its 10-year median of 28.47. Vijaya Diagnostic Centre's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current Pretax Margin % is 29.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,341.10 is trading 12.6% above its estimated GF Value™ of ₹1,191.11.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
Pretax Margin %: 29.30% (near median its 10-year median of 28.47)
GF Value™: ₹1,191.11 vs. price of ₹1,341.10 (12.6% above fair value)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
83GF Score
Get the complete analysis for BOM:543350
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
